IMI Stakeholder Forum 2020

Start Date 10/11/2020
IMI Executive Director Pierre Meulien

The IMI Stakeholder Forum 2020 took place online on Tuesday 10 November. The theme this year was 'Broader horizons: growing Europe’s health partnership'.

We launched the last calls for IMI2 this year, and the Stakeholder Forum allowed us to take stock of what was achieved, and the many lessons we’ve learned around what has worked well. We also explored what can be improved upon, and look forward to a new adventure being proposed under Horizon Europe.

The event featured leaders in both policy making and science and technology expertise.

We focused on paediatric cancers to demonstrate how a new partnership would bring new stakeholders together, synergise with the Cancer Mission and be more inclusive in the co-creation of ideas for the programme.  We also took this opportunity to listen to you – our stakeholders - to help develop the new partnership, avoid pitfalls and build together a world leading collaboration.

 

Agenda

Please find the agenda here.

 

Event outline 

 

You can access all the recordings here

 

Opening

(recording)

  • Pierre Meulien, Executive Director, IMI

 

Looking to the future of health research 

(recording)

  • Jean Eric Paquet, Director-General for Research and Innovation, European Commission
  • Irene Norstedt, Acting Director of the People Directorate, Directorate-General for Research and Innovation, European Commission
  • Olivier Laureau, President, Servier group
  • Jan Kimpen, Global Chief Medical Officer, Philips
  • Mark Miller, Executive Vice-President - Chief Medical Officer, bioMérieux
     

Integrating health research and innovation – paediatric cancer as a test case

(recording)

  • Ruth Lydia Ladenstein, Professor of Paediatrics and Head of the Clinical Trials Unit S²IRP – CCRI, St. Anna Children’s Hospital
  • Gilles Vassal, Professor of Oncology, University Paris XI, Gustave Roussy Comprehensive Cancer Center 
  • Annette Bakker, President, Children's Tumor Foundation
  • Salah-Dine Chibout, Global Head of Discovery and Investigational Safety, Novartis
  • Pablo Guijarro Masi, Reimbursement & Health Economics Manager Brain Modulation, Medtronic 

 

Closing speech

(recording)

  • Maria da Graça Carvalho, Member of the European Parliament

 

Conclusion

(recording)

  • Pierre Meulien, Executive Director, IMI

 

More information

To stay up to date with the event developments, sign up to our newsletter, or follow us on Twitter (@IMI_JU) or LinkedIn.